TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Successful device implantation at 24 months postop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Efinopegdutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of Efinopegdutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (ORR) (Arm 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall response rate (ORR) (Arm 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Radiological changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported PTSD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: stress in parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: depression in parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: family management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rate of x-rays
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of Nephrogenic Diabetes Insipidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow resistance indices (S/D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Purpose in life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immune response to COVID-19 vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Self-Care Behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Adherence and assessment completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful sentinel lymph node biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of perioperative major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: COPD related readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: systolic femoral invasive blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circulating GlaOC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Success of virtual reality mask for analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Care load of caregivers
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Cmax of unconjugated dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of unconjugated dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of mitophagy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events grade III-IV
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of severe Cytokine release syndrome (CRS) and Immune effector cell-associated neurotoxicity syndrome (ICANS)
Endpoint domain: Adverse events/effects
Primary endpoint: Non-relapse treatment-related mortality (NRM)
Endpoint domain: Mortality/survival
Primary endpoint: malaria incidence
Endpoint domain: Mortality/survival
Primary endpoint: Time to viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in social functioning as measured by NIH Toolbox Surveys
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Clinic Level Implementation Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cough peak expiratory flow evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of atrial tachycardia episodes per participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall duration of atrial tachycardia episodes per participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number and severity of RSV-infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent of callers screened and eligible to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of eligible callers who enroll in the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent who complete the endpoint assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall treatment effect of ATH-1017
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean fold change in the quantities of P. gingivalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean fold change in the quantities of T.denticola
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean fold change in the quantities of T.forsythia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity for the diagnosis of advanced hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Accuracy of diagnosis of common bile duct stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of S-EPTS/LM-PCR methodology for RIS analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of S-EPTS/LM-PCR methodology for RIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burnout risk
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recovery need
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Emotion Regulation - Adolescent Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotion Regulation - Parent Report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental health - Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental health - Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negativation of JCV viral load in the CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Pressure of Maximum Tolerance in mmHg of the Rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Exogenous Leucine Oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Net Leucine Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in 10 Meter Walk Test speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Reporting Adverse Events (AEs) Within 1 Month After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Reporting Serious Adverse Events (SAEs) Throughout the Sub Study
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titer (GMT) of Neutralizing Titers (NT) for Each RSV Subgroup 1 Month After Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Taste preference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported adherence to the prescribed amount of study product
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fractional Exhaled Nitric Oxide (FeNO) at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fractional Exhaled Nitric Oxide (FeNO) before/after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Facial Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milligram morphine equivalents (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Eligible Patients Who Agree to Participate in the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Screening Failure Percentage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Completed the Follow-up Evaluation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severity of intrusions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parents' communication behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volume measurement of brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Thickness measurement of brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral blood flow measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of successful sedation without hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knee adduction moment (KAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ITD-IAD-M Assessment tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in secretin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative pain measured with the visual analogic scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain measured by the number of rescue painkillers needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of toxicities associated with PCI-24781/Abexinostat and metronomic temozolomide therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Ambulatory medical assistance efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time 0 to Last Measurable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time 0 to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite complete remission (CRc) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in EDSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in best corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Continued Treatment With Apixaban or Warfarin Following Discharge From the Hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Who Discontinued Index Treatment at 6 Months Post-Discharge Index Date
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Who Discontinued Index Treatment at 12 Months Post-Discharge Index Date
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in parent stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in children's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in children's activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Magnitude of change in RMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return RMR to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of serum Manganese
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum selenium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum Iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum copper
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum Zinc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lower Limb Assessment Score (LLAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beighton Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracellular tacrolimus concentration in CD3+ T lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 3 Meter Backward Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-Square Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline maternal depressive symptoms at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline maternal posttraumatic stress symptoms at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline child behavior at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Colony forming units (CFU/cm2) in the emergency department
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Colony forming units (CFU/cm2) in the operating theatre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MRI assessment of cardiac structure at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MRI assessment of cardiac function at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal exercise MRI assessment of cardiac structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardioplumonary Exercise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative frequency of different aetiologies of ATM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative vaccine effectiveness for hospitalization for influenza and/or pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Relative vaccine effectiveness for hospitalization for respiratory disease
Endpoint domain: Mortality/survival
Primary endpoint: Relative vaccine effectiveness for hospitalization for all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Culprit or same-class medication re-dispensing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction of the initial HAM-D score by 50% or more at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of the HAM-D score to less than 7 at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression change in score achievement to very much improved or much improved at week 8
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of Bregs in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Healthcare worker burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in depressive symptoms, stress levels and anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of sports drink vs water as a solvent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Willingness to participate in exposure in vivo
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance rate of weekly yoga intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in Conscious Levels Measured by Glasgow Coma Scale (GCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of Intubation Requirement Using APACHE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Intensive Care Unit (ICU) Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hemoglobin A1c less than 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement or Resolution of Hydronephrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Skin elasticity/firmness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Objective Prospective Memory Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient-Centered/Patient-Selected Prospective Memory Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Caregiving-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Needs Satisfaction and Frustration Scale (NSFS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General Self-Efficacy Scale (GSE-10)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Resilience Scale (RS-14)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CRIES Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ki67
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathological response to NAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Assessment of residual disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of patients with cardiovascular collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mobile application rating scale (MARS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma activity curve of pegaspargase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between prevalence rates of non-adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative butorphanol dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: WHO toxicity scale
Endpoint domain: Adverse events/effects
Primary endpoint: Change in diameter of the cerebral arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Glycated Hemoglobin (HbA1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain Experienced by Tape Removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of peripheral blood mononuclear cells (PBMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes of 2,3-BPG levels in erythrocyte
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Endurance time on cycloergometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 minutes pegboard and ring test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who enroll in cessation services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Vaping cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Rating Scale of Swallowing Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days on medications for opioid disorder (MOUD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New COVID-19 Group Home Incidence
Endpoint domain: Mortality/survival
Primary endpoint: Diet Counseling Competence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Diet Counseling Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diet Counseling Skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Geometric Mean Titers (GMTs) of Full-Length S-Binding IgG Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Local Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Olfactory score on the UPSIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gustatory score on the WETT-SA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes